Holen Sie sich die Stockscreener-App
17.87
2.41%
0.42
Handel nachbörslich:
17.52
-0.35
-1.96%
Schlusskurs vom Vortag:
$17.45
Offen:
$17.51
24-Stunden-Volumen:
164.41K
Relative Volume:
0.36
Marktkapitalisierung:
$479.23M
Einnahmen:
$31.38M
Nettoeinkommen (Verlust:
$-6.69M
KGV:
-68.73
EPS:
-0.26
Netto-Cashflow:
$-1.84M
1W Leistung:
+3.41%
1M Leistung:
+24.18%
6M Leistung:
+17.72%
1J Leistung:
+287.64%
1-Tages-Spanne:
$17.31
$18.07
1-Wochen-Bereich:
$16.69
$18.07
52-Wochen-Spanne:
$4.52
$21.48
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Vergleichen Sie ETON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
17.87 | 460.99M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Bestätigt | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-01-06 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-06 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Technical signs of recovery in Eton Pharmaceuticals IncWeekly Risk Summary & Weekly Momentum Picks - Newser
Risk vs reward if holding onto Eton Pharmaceuticals Inc.2025 Top Decliners & Community Consensus Trade Signals - Newser
Live market analysis of Eton Pharmaceuticals Inc.Quarterly Profit Review & Weekly Breakout Stock Alerts - Newser
How to read the order book for Eton Pharmaceuticals Inc.2025 Top Gainers & Technical Pattern Alert System - Newser
Can momentum traders help lift Eton Pharmaceuticals Inc.Weekly Trading Summary & Verified Momentum Stock Watchlist - Newser
What recovery options are there for Eton Pharmaceuticals Inc.Quarterly Growth Report & AI Driven Stock Reports - Newser
Technical signs of recovery in Eton Pharmaceuticals Inc.Weekly Volume Report & Capital Protection Trade Alerts - Newser
Applying big data sentiment scoring on Eton Pharmaceuticals Inc.Rate Cut & Fast Gain Swing Trade Alerts - Newser
Analyzing recovery setups for Eton Pharmaceuticals Inc. investorsWeekly Gains Summary & AI Optimized Trade Strategies - Newser
Price momentum metrics for Eton Pharmaceuticals Inc. explained2025 Year in Review & Proven Capital Preservation Tips - Newser
Eton Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Update & Fast Gain Stock Trading Tips - Newser
Visual analytics tools that track Eton Pharmaceuticals Inc. performanceDollar Strength & Daily Profit Focused Screening - Newser
Building trade automation scripts for Eton Pharmaceuticals Inc.Quarterly Performance Summary & Smart Allocation Stock Tips - Newser
Can machine learning forecast Eton Pharmaceuticals Inc. recoveryAnalyst Downgrade & High Conviction Buy Zone Alerts - Newser
What candlestick patterns are forming on Eton Pharmaceuticals Inc.2025 Dividend Review & Free Community Consensus Stock Picks - Newser
How to forecast Eton Pharmaceuticals Inc. trends using time seriesJuly 2025 Reactions & High Accuracy Investment Signals - Newser
Top chart patterns to watch in Eton Pharmaceuticals Inc.Trade Analysis Report & Daily Oversold Bounce Ideas - Newser
Will breakout in Eton Pharmaceuticals Inc. lead to full recoveryJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - Newser
Real time alert setup for Eton Pharmaceuticals Inc. performanceQuarterly Portfolio Review & Free High Return Stock Watch Alerts - Newser
How does Eton Pharmaceuticals Inc. compare to its peers2025 Market Sentiment & Safe Investment Capital Preservation Plans - khodrobank.com
What MACD and RSI say about Eton Pharmaceuticals Inc.Quarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Analyzing Eton Pharmaceuticals Inc. with risk reward ratio charts2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Published on: 2025-09-01 02:04:33 - beatles.ru
Ranking Eton Pharmaceuticals Inc. among high performing stocks via toolsJuly 2025 Rallies & Detailed Earnings Play Strategies - Newser
What institutional flow reveals about Eton Pharmaceuticals Inc.Forecast Cut & Capital Efficient Trade Techniques - Newser
Analyzing net buyer seller activity in Eton Pharmaceuticals Inc.Trade Risk Report & Smart Swing Trading Techniques - Newser
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Using data models to predict Eton Pharmaceuticals Inc. stock movementExit Point & Verified Short-Term Trading Plans - Newser
How high can Eton Pharmaceuticals Inc. stock go2025 Market WrapUp & Safe Entry Point Identification - Newser
Can technical indicators confirm Eton Pharmaceuticals Inc.’s reversal2025 Dividend Review & Free Community Consensus Stock Picks - Newser
Can Eton Pharmaceuticals Inc. recover in the next quarterBear Alert & Verified Trade Idea Suggestions - Newser
Full technical analysis of Eton Pharmaceuticals Inc. stockJuly 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersOptions Play & Weekly Breakout Watchlists - Newser
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Eton Pharmaceuticals Inc-Aktie (ETON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gruber James R. | Chief Financial Officer |
Aug 20 '25 |
Sale |
16.02 |
2,631 |
42,149 |
204,753 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):